Kyverna Therapeutics Inc.
KYTX | NASDAQ
$7.12
-$0.01 (-0.14%)
At close: Sep 21, 2026, 4:00 PM ET
$7.07
-$0.05 (-0.64%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Institutional Ownership
Net InflowTotal Institutions
116
Total Ownership
57.62%
Capital Flow
+$20.42M
Shares Change
+673.8K
Ownership Distribution
Institutions (57.62%)
Others (42.38%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
28
Increased Positions
58
Reduced Positions
36
Closed Positions
16
New (28)
Increased (58)
Reduced (36)
Closed (16)
Options Sentiment & Activity
bullishPut/Call Ratio
0.254
Call Flow
131,016
Put Flow
33,300
Calls (80%)
Puts (20%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Point72 Asset Management LP | 0.37% +592.67% | < 0.01% | 222.93K | 1.8M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Gordonmd Global Investments LP | 7.02% -24.58% | 25.51% -13.80% | 4.24M -3.35% | 36.63M -11.26% | |
| Gilead Sciences, Inc. | 6.83% -21.97% | 1.68% -16.09% | 4.13M 0.00% | 35.61M -8.19% | |
| Bain Capital Life Sciences Investors, LLC | 5.15% -21.97% | 2.42% +8.11% | 3.11M 0.00% | 26.84M -8.19% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove KYTX